Character Biosciences has raised $93m in an oversubscribed Series B funding round to expedite the progression of precision therapies for degenerative eye conditions, beginning with age-related ...

Innovation Endeavors, and S32. Tempero, EpiCrispr Hillstar, and Ampersand also raise funds Also this week, Tempero Bio – a developer of medicines for substance use disorders (SUDs ...

The funding was co-led by new investors aMoon and Luma Group, with additional participation from Bausch + Lomb and Jefferson Life Sciences, alongside existing investors Innovation Endeavors ...

"... The best way to insulate against corporate relocation is to continuously grow new, large, impactful companies. And, if ...

Join us in celebrating the excellence of business and visionary leaders who inspire growth, foster innovation and contribute ...

Amanda Freund, a Connecticut dairy farmer is headed to "Shark Tank," where she aims to propel her creation, CowPots, into the ...

Prince William County's DEDT is helping the region grow into one of the top life sciences sectors in the U.S., with its ...

Me might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible, ...

The funding was co-led by new investors aMoon and Luma Group, with additional participation from Bausch + Lomb and Jefferson Life Sciences, alongside existing investors Innovation Endeavors, Catalio ...

Existing investors Innovation Endeavors, Catalio Capital Management, S32, and KdT Ventures also contributed. According to the company, the funding will help fund phase 1 and phase 2 proof-of-concept ...